Predictors of rebleeding and in-hospital mortality in patients with nonvariceal upper digestive bleeding

Table 6 Clinical and endoscopic features of the study population: Association with deaths due to bleeding

Parameter	Survivors (no. pts)	Deaths due to bleeding (no. pts)	P value
Gender	1534	47	0.989
Lesion	1534	47	0.140
Rockall score	1514	43	< 0.001
Simple therapy	167	7	0.196
Combined therapy	363	12	0.966
SBP < 100 mmHg	252	36	< 0.001
Pulse > 100 beats per minute	429	34	< 0.001
Rebleeding	113	10	< 0.001
No. blood units	1532	47	< 0.001
Aspirin	310	6	0.451
NSAIDs	240	5	0.350
Surgery	51		0.204
Antiaggregants	104	2	0.179
Anticoagulants	93	7	0.110
Cardiovascular comorbidities			0.221
Diabetes mellitus	189	12	0.224
Respiratory comorbidities	189	17	< 0.001
Renal comorbidities	320	10	0.945
Liver cirrhosis	134	7	0.145
Neoplasias	248	8	0.876
Neurologic comorbidities	209	5	0.556
Obesity	133	1	0.113
Sepsis	42	5	0.002
Acute pancreatitis	4	4	0.620
Acute abdomen	5	1	0.048

SBP: Systolic blood pressure; NSAIDs: Non-steroidal anti-inflammatory drugs.